Andrew Orth compensation by year
Krystal Biotech Summary Compensation Table · all 3 fiscal years held| Component | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Salary | $283,333 | $445,833 | $276,515 |
| Bonus | $130,508 | $202,500 | $0 |
| Stock awards | $0 | $0 | $819,100 |
| Option awards | $8,579,300 | $2,189,636 | $1,141,004 |
| Non-equity incentive | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $9,917 | $12,200 | $27,709 |
| Total | $9,003,058 | $2,850,169 | $2,264,328 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Krystal Biotech, Inc. DEF 14A filed April 4, 2024, accession 0001711279-24-000013, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Krystal Biotech, Inc. filed document, accession 0001711279-24-000013. Every figure is read from that document and cited to the page and table it appears in. Filed April 4, 2024.
Krystal Biotech’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| Krish Krishnan | Chair and Chief Executive Officer | $6,223,894 |
| Suma Krishnan | President, R&D | $3,835,481 |
| Kathryn Romano | Chief Accounting Officer | $2,574,971 |
| Andrew Orth · this page | Chief Commercial Officer | $2,264,328 |
The full Krystal Biotech compensation record
free company briefThis page is one person within Krystal Biotech's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Krystal Biotech proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Krystal Biotech's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.